Table 2 Target- and cohort-specific mutation prevalence
Target | CA-SMK | NC-SMK | NC-NON | NC-TOT | Average (All Subjects) |
|---|---|---|---|---|---|
BRAF_15 | 6.7 × 10− 3 | 0 | 0 | 0 | 3.9 × 10− 3 |
EGFR_18 | 0 | 0 | 0 | 0 | 0 |
EGFR_19 | 0 | 0 | 0 | 0 | 0 |
EGFR_20 | 3.9 × 10−2 | 3.4 × 10− 2 | 4.5 × 10− 2 | 3.8 × 10− 2 | 3.8 × 10− 2 |
EGFR_21 | 1.7 × 10− 3 | 0 | 0 | 0 | 9.9 × 10− 4 |
ERBB2 | 1.1 × 10− 2 | 1.4 × 10− 2 | 1.4 × 10− 2 | 1.4 × 10− 2 | 1.2 × 10− 2 |
KRAS_2 | 0 | 0 | 0 | 0 | 0 |
PIK3CA_10 | 4.2 × 10− 3 | 0 | 0 | 0 | 2.4 × 10− 3 |
TP53_5 | 2.2 × 10− 2 | 4.7 × 10− 3 | 0 | 2.9 × 10− 3 | 1.4 × 10− 2 |
TP53_6 | 2.2 × 10− 2 | 0 | 3.1 × 10− 3 | 1.2 × 10− 3 | 1.3 × 10− 2 |
TP53_7 | 1.3 × 10− 2 | 2.9 × 10− 3 | 0 | 1.8 × 10− 3 | 8.5 × 10− 3 |
Average (All Targets) | 1.2 × 10− 2 | 4.7 × 10− 3 | 5.3 × 10− 3 | 4.9 × 10− 3 | 8.9 × 10− 3 |